- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis) in United Kingdom
Total 411 results
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingWaldenstrom Macroglobulinemia | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Amyloidosis | Waldenstrom's Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsRecruitingCardiomyopathy | Amyloidosis, PrimaryUnited States
-
The Cleveland ClinicCompletedAmyloidosis | Spinal Stenosis | Amyloid | Transthyretin Amyloidosis | Primary Amyloidosis of Light Chain TypeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Secondary AmyloidosisUnited States
-
The Cleveland ClinicCompletedAmyloidosis | Transthyretin Amyloidosis | Trigger Finger | Primary Amyloidosis of Light Chain TypeUnited States
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
Boston Medical CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Yale UniversityCompletedMultiple Myeloma | Influenza | Waldenstrom's Macroglobulinemia | MGUS | Plasma Cell DisordersUnited States
-
National Cancer Institute (NCI)CompletedWaldenström Macroglobulinemia | Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Temple UniversityCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
GlaxoSmithKlineCompletedWaldenstrom MacroglobulinaemiaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMultiple Myeloma | AL AmyloidosisUnited States
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
University College, LondonMerck Sharp & Dohme LLCCompletedWaldenstrom MacroglobulinemiaUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompletedMultiple Myeloma | Primary AmyloidosisUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingMultiple Myeloma | Lymphoblastic Lymphoma | Waldenstrom's Macroglobulinemia | Smoldering Multiple MyelomaUnited States
-
University of Alabama at BirminghamRecruitingMultiple Myeloma | Amyloidosis | Plasma Cell LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompletedMultiple MyelomaUnited States
-
University College, LondonJanssen-Cilag Ltd.RecruitingWaldenstrom MacroglobulinemiaUnited Kingdom
-
AmgenCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Hodgkin's DiseaseUnited States
-
TG Therapeutics, Inc.CompletedB-cell Lymphoma | Marginal Zone Lymphoma | Primary Central Nervous System Lymphoma | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
University of RochesterGlaxoSmithKlineCompletedChronic Lymphocytic Leukemia (CLL) | Waldenstrom Macroglobulinemia (WM)United States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States
-
University of TennesseeCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedLymphoproliferative Disorders | Leukemia | Multiple Myeloma | Myelodysplastic Disorders | Plasma Cell DyscrasiaUnited States
-
The Cleveland ClinicActive, not recruitingAL Amyloidosis | Amyloidosis | Amyloid Neuropathies, Familial | Amyloid | Transthyretin Amyloidosis | Amyloid Cardiomyopathy | Amyloid - PrimaryUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Acute Leukemia | Chronic LeukemiaUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms MacroglobulinaemiaPoland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
-
Barbara Ann Karmanos Cancer InstituteCompletedMultiple Myeloma | AL Amyloidosis | Chronic Lymphocytic LeukemiaUnited States
-
Tufts Medical CenterNational Institute on Aging (NIA)CompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Boston Medical CenterTerminatedMultiple Myeloma | Plasma Cell NeoplasmUnited States